Vitamin D receptor is a novel drug target for ovarian cancer treatment.
about
Serum vitamin D3 level inversely correlates with uterine fibroid volume in different ethnic groups: a cross-sectional observational studyVitamin D suppresses leptin stimulation of cancer growth through microRNA.Vitamin D and the epigenome.The coupling of epidermal growth factor receptor down regulation by 1alpha,25-dihydroxyvitamin D3 to the hormone-induced cell cycle arrest at the G1-S checkpoint in ovarian cancer cells.Effects of 1α,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cellsSuppression of epithelial ovarian cancer invasion into the omentum by 1α,25-dihydroxyvitamin D3 and its receptorMechanistic Effects of Calcitriol in Cancer BiologyRace/Ethnicity-Specific Association of Vitamin D and Global DNA Methylation: Cross-Sectional and Interventional Findings.Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition.1,25-Dihydroxyvitamin D3 suppresses telomerase expression and human cancer growth through microRNA-498.Polymorphic variants in the vitamin D pathway genes and the risk of ovarian cancer among non-carriers of BRCA1/BRCA2 mutationsVitamin D receptor gene BsmI and FokI polymorphisms in relation to ovarian cancer risk in the Polish populationVitamin D3 stimulates embryonic stem cells but inhibits migration and growth of ovarian cancer and teratocarcinoma cell lines24-Hydroxylase in cancer: impact on vitamin D-based anticancer therapeutics.Low fertility may be a significant determinant of ovarian cancer worldwide: an ecological analysis of cross- sectional data from 182 countries
P2860
Q24611298-100BBF38-28A5-4AF8-876A-9B06275BD95FQ30367127-574A9393-A844-414D-BD03-0D846A7DE901Q33569349-9557FA10-2A4B-4CB5-B957-55CDF8E3938CQ34949693-1B24B4E6-CFE2-4709-B872-5997374C7499Q35038553-F4486267-9B80-4BE2-8B57-8FA009D202D7Q35737779-1C6B13B6-D616-4163-A143-4FC81D1F5C83Q35809076-32BE8300-2B80-4118-8053-5602F2DE4E6EQ35980777-CB6F8772-C0D6-449E-98DC-4C14F709AF5AQ36144711-E30FD08D-5FD6-4FC3-92D6-517A9630F6F4Q36436094-4A65948B-9621-4AC3-B54B-EE603EB3CE0AQ36524235-EB2EB503-AE76-489C-A131-2C30F1E59117Q36638586-22D60615-8695-4927-B143-94F988288E59Q36810553-59D33450-D1AF-446F-8701-412EAD5C4822Q38051505-110B8746-ADEE-4F0C-9F71-508F5A501D1DQ58774206-AEAD4C8E-AAD4-4C47-96F0-245E6FC38893
P2860
Vitamin D receptor is a novel drug target for ovarian cancer treatment.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Vitamin D receptor is a novel drug target for ovarian cancer treatment.
@ast
Vitamin D receptor is a novel drug target for ovarian cancer treatment.
@en
Vitamin D receptor is a novel drug target for ovarian cancer treatment.
@nl
type
label
Vitamin D receptor is a novel drug target for ovarian cancer treatment.
@ast
Vitamin D receptor is a novel drug target for ovarian cancer treatment.
@en
Vitamin D receptor is a novel drug target for ovarian cancer treatment.
@nl
prefLabel
Vitamin D receptor is a novel drug target for ovarian cancer treatment.
@ast
Vitamin D receptor is a novel drug target for ovarian cancer treatment.
@en
Vitamin D receptor is a novel drug target for ovarian cancer treatment.
@nl
P2093
P1476
Vitamin D receptor is a novel drug target for ovarian cancer treatment.
@en
P2093
Santo V Nicosia
Wenlong Bai
Xiaohui Zhang
P304
P356
10.2174/156800906776842939
P577
2006-05-01T00:00:00Z